Company / Current Liabilities per Share
MoonLake Immunotherapeutics Current Liabilities per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.71
FY2025
5-year range
$0.20 / $2.69
FY2021-FY2025
Trend
+97.5%
vs FY2024
Sector context
#132 of 210
Health Care
What the data says
At $0.71, MoonLake Immunotherapeutics's current liabilities per share ranks #79 of 210 in the Health Care sector. Increased from $0.20 to $0.71 over the past 2 years.
Based on SEC 10-K filings.
0.71 in FY2025 with a 5-year CAGR of +103.8%.
Increased from $0.20 to $0.71 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +39.3%
- 5-Year CAGR
- +103.8%
- 10-Year CAGR
- -
Sector benchmark
#79 of 210 in Health CareTop 37% of 210This company $0.71 Sector average $23.79
▼
-97.0% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 97.5% year-over-year.
- Ranks #132 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2021.
- Lowest current liabilities per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.71 | +97.5% |
| FY2024 | $0.36 | +76.1% |
| FY2023 | $0.20 | -22.3% |
| FY2022 | $0.26 | -90.3% |
| FY2021 | $2.69 | +13289.4% |
| FY2020 | $0.02 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026